Seeking Alpha

KYTH
  KYTHERA Biopharmaceuticals - NASDAQ

9/19/2014, 11:01 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
KYTH vs. ETF Alternatives
Company Description
KYTHERA Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market.